Yoshiyuki Takahashi Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Significantly reduced relapse rate after KIR ligand incompatible allogeneic cord blood transplantation with nonmyeloablative conditioning for primary stage IV neuroblastoma — Poster Session 1 with wine & cheese